Biomea Fusion, Inc. Common Stock
€1.198
EUR
Last updated on --.
24h volume900.00
24h highest1.1933 EUR
24h lowest1.1873 EUR
24h Price movement-1.06%
BMEA recent prices
24 Hours
-1.06%-€0.012886
30 days
-19.36%-€0.2878
60 days
+7.58%+€0.08591
90 days
-3.79%-€0.047251
Key data
Previous close1.2113 EUR
Market cap82.61M EUR
Volume900.00
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.53264 EUR
Net income (FY)-38.62M EUR
Revenue (FY)--
Last report dateMay 11, 2026
About Biomea Fusion, Inc. Common Stock
HeadquartersSAN CARLOS
Employees (FY)40.00
Net income per employee (FY)-965.41K EUR
Listed onNasdaq
BMEA conversion tables
 |  |
|---|---|
| 0.5 BMEA | 0.59922 EUR |
| 1 BMEA | 1.198 EUR |
| 5 BMEA | 5.992 EUR |
| 10 BMEA | 11.98 EUR |
| |
|---|---|
| 0.5 EUR | 0.41721 BMEA |
| 1 EUR | 0.83441 BMEA |
| 5 EUR | 4.172 BMEA |
| 10 EUR | 8.344 BMEA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BMEA is trading at €1.198, -1.06% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BMEA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BMEA is currently trading at €1.198, -1.06% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BMEA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BMEA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BMEA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BMEA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Biomea Fusion, Inc. Common Stock's market cap is currently 82.61M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume900.00
24h highest1.1933 EUR
24h lowest1.1873 EUR
24h Price movement-1.06%
Start trade with BMEA Perpetual
Sign up to trade